drugset / Trial / NCT04517890

Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

NCT04517890 ↗

Unknown 200 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

aims to investigate the effectiveness of Transdermal lidocaine patch for Pain Control During Levonorgestrel Releasing Intrauterine System Insertion in Women Delivered Only by Elective Cesarean Section

Timeline

Start
2020-09-01
Primary completion
2021-08-31
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical